Vanda Pharmaceuticals Inc’s recently made public that its SVP, CFO & Treasurer Moran Kevin Patrick unloaded Company’s shares for reported $13327.0 on Jul 29 ’24. In the deal valued at $5.92 per share,2,251 shares were sold. As a result of this transaction, Moran Kevin Patrick now holds 228,763 shares worth roughly $1.1 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Moran Kevin Patrick bought 2,251 shares, generating $13,327 in total proceeds.
Before that, Williams Timothy sold 8,941 shares. Vanda Pharmaceuticals Inc shares valued at $37,396 were divested by the SVP & General Counsel at a price of $4.18 per share. As a result of the transaction, Williams Timothy now holds 196,825 shares, worth roughly $0.94 million.
H.C. Wainwright initiated its Vanda Pharmaceuticals Inc [VNDA] rating to a Buy in a research note published on October 31, 2024; the price target was $18. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid July with a ‘”an Overweight”‘ rating. Jefferies also remained covering VNDA and has decreased its forecast on February 25, 2022 with a “Hold” recommendation from previously “Buy” rating. BofA Securities started covering the stock on May 12, 2021. It rated VNDA as “a Buy”.
Price Performance Review of VNDA
On Tuesday, Vanda Pharmaceuticals Inc [NASDAQ:VNDA] saw its stock fall -1.24% to $4.79. Over the last five days, the stock has gained 2.13%. Vanda Pharmaceuticals Inc shares have risen nearly 13.51% since the year began. Nevertheless, the stocks have risen 5.97% over the past one year. While a 52-week high of $6.75 was reached on 06/13/24, a 52-week low of $3.30 was recorded on 02/06/24. SMA at 50 days reached $4.80, while 200 days put it at $4.89.
Levels Of Support And Resistance For VNDA Stock
The 24-hour chart illustrates a support level at 4.70, which if violated will result in even more drops to 4.61. On the upside, there is a resistance level at 4.84. A further resistance level may holdings at 4.89. The Relative Strength Index (RSI) on the 14-day chart is 52.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.06, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 30.43%. Stochastics %K at 60.44% indicates the stock is a holding.
How much short interest is there in Vanda Pharmaceuticals Inc?
A steep rise in short interest was recorded in Vanda Pharmaceuticals Inc stocks on 2024-10-15, growing by 0.63 million shares to a total of 3.98 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 3.35 million shares. There was a rise of 15.72%, which implies that there is a positive sentiment for the stock.
